AI In Oncology For Analytical Solutions Market
AI In Oncology For Analytical Solutions Market - Global Industry Assessment & Forecast
#
Pages:
144
2021
May - 2023
VMR-2134
Segments Covered
By
Component Data Licensing Services, Software Solutions, Analytics & Other Services
-
By
Cancer Type Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-Hodgkin Lymphoma, Bladder Cancer
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2021 |
| Forecast
Years:
|
2022 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
USD 549.6 Million |
 Revenue 2028:
|
USD 4852.6 Million |
 Revenue CAGR
(2022 - 2028): |
36.5% |
Fastest Growing Region (2022 -
2028)
|
Asia Pacific |
Largest Region (2021):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2016 to 2020 |
| 3. | Forecast Data | 2022 to 2028 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for AI In Oncology For Analytical Solutions in terms of revenue?
-
The global AI In Oncology For Analytical Solutions valued at USD 549.6 Million in 2021 and is expected to reach USD 4852.6 Million in 2028 growing at a CAGR of 36.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Azra AI (U.S.), International Business Machine (U.S.), Siemens Healthineers (Germany), Intel Corp. (U.S.), GE Healthcare (U.S.), NVIDIA (U.S.), Digital Diagnostics Inc. (U.S.), Concert.AI (U.S.), Median Technologies (France), Path AI (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 36.5% between 2022 and 2028.
What are the driving factors fueling the growth of the market.
-
The driving factors of the AI In Oncology For Analytical Solutions include
- Surging Advancements in Healthcare Infrastructure
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the AI In Oncology For Analytical Solutions in 2021.
